It was found that Gd-based MRI CAs conjugated with NSAIDs suppressed the increase in cyclooxygenase-2 (COX-2) levels, ameliorated glial activation, and neuron damage that is phenotypic for stroke by mitigating neuroinflammation, which prevented reperfusion injury. Here, PTGS2 is linked to stroke disorder.